Presented
by

Presented by Oxford Global

Discover PLUS Pass

All Discovery Content

Bringing you the latest research in Drug Discovery In New Modalities, Integration Of DEL, Covalent Inhibitors, Protein Degradation Technologies, Computational Drug Design & Automation Strategies and more, through a range of Speaker Interviews, Industry Insights, and Expert Opinions.
Industry Spotlight
Biophysical Tools for the Design and Development of PROTACs
Protein degradation has emerged as a promising new field of therapeutics. What are biophysical tools are employed for the characterisation of these drugs?
Edited by Tom Cohen |
19 October 2023
Medicinal Chemistry & Drug Design
Industry Spotlight
RNA Interference: Looking Back at the 2006 Nobel Prize
Fire and Mello’s research has unlocked a powerful new therapeutic technology: silencing genes with siRNA.
Edited by Tom Cohen |
09 May 2023
Medicinal Chemistry & Drug Design
Video Content
Video Q&A
Interview with Andrew Robertson, Vice President, Head of Global Regulatory Policy and Innovation at Takeda
Andrew Robertson, Vice President, Head of Global Regulatory Policy and Innovation at Takeda, talks about working with regulators and the current regulatory paradigm.
Edited by Tom Cohen |
28 March 2023
Medicinal Chemistry & Drug Design
Discussion Group Report
Automation Experts Discuss New Platform for Synthesis in Organic Chemistry
Our Discussion Group featured expert conversation on automation and synthesis from software to hardware, key challenges, and end goals.
Edited by Tom Cohen |
26 January 2023
Medicinal Chemistry & Drug Design
Industry Spotlight
Bicycle Therapeutics Publishes Preclinical Data from Nectin-4 Targeting Cancer Drug
A paper published in the Journal of Medicinal Chemistry highlights Cambridge, UK based biotech, Bicycle Therapeutics’ findings regarding bicycle toxin conjugate, BT8009.
Edited by Tom Cohen |
11 October 2022
Medicinal Chemistry & Drug Design
Commentary
Shooting for the StaRs: Stabilising GPCRs and Mapping Their Structure
Japanese-UK biotech Sosei Heptares are tackling the problem of stabilising GPCR structures with a view toward novel drug discovery endpoints.
07 October 2022
Medicinal Chemistry & Drug Design
Whitepaper
Mcule: Compound Sourcing Expert
Mcule is a leading chemical marketplace for drug discovery where you can order small-molecule samples from a high-quality database. We acquire the compounds from the manufacturers and deliver them in a consolidated package, in the format specified by you
21 April 2022
Medicinal Chemistry & Drug Design
Whitepaper
PeproTech: Price List
Helping unlock the promise of Cellular Therapies and Regenerative Medicines
21 April 2022
Medicinal Chemistry & Drug Design
Whitepaper
MCE: Inhibitors & Agonists - Compound Screening Libraries
25,000+ selective Inhibitors and Agonists Targeting 375 key proteins in 20+ signaling pathways Applications in different disease areas. MCE Compound Screening Libraries consist of10,000+ small molecules with validated biological and pharmacological activities.
15 November 2021
Medicinal Chemistry & Drug Design
Whitepaper
MCE: Life Science Product Catalog
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use
15 November 2021
Medicinal Chemistry & Drug Design

Search by Keyword

Filter by Subject Area

Discovery Series – Subject

Filter by Content Type

Resource Formats (incl. Industry Spotlight)

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Twitter Linkedin-in

Event Series

About

Careers

Legal

Copyright Oxford Global Marketing Limited. All rights reserved.